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Abstract
Background:  TDP-43 is an evolutionarily conserved RNA-binding protein implicated in the
pathogenesis of frontotemporal dementia (FTD), sporadic and familial amyotrophic lateral sclerosis
(ALS), and possibly other neurodegenerative diseases. In diseased neurons, TDP-43 is depleted in
the nucleus, suggesting a loss-of-function pathogenic mechanism. However, the normal function of
TDP-43 in postmitotic neurons is largely unknown.
Results: Here we demonstrate that overexpression of Drosophila TDP-43 (dTDP-43) in vivo
significantly increases dendritic branching of sensory neurons in Drosophila larvae. Loss of dTDP-43
function, either in a genetic null mutant or through RNAi knockdown, decreased dendritic
branching. Further genetic analysis demonstrated a cell-autonomous role for dTDP-43 in dendrite
formation. Moreover, human TDP-43 (hTDP-43) promoted dendritic branching in Drosophila
neurons, and this function was attenuated by mutations associated with ALS.
Conclusion: These findings reveal an essential role for TDP-43 in dendritic structural integrity,
supporting the notion that loss of normal TDP-43 function in diseased neurons may compromise
neuronal connectivity before neuronal cell loss in FTD and ALS.
Background
Frontotemporal lobar degeneration (FTLD) is a devastat-
ing age-dependent neurodegenerative condition primarily
associated with impairments in cognition and social
behaviors, as well as personality changes and other clini-
cal abnormalities [1]. Frontotemporal dementia (FTD), a
major clinical syndrome of FTLD, is now recognized as the
most common form of early-onset age-dependent demen-
tia before the age of 60 [2]. Increasing clinical, pathologi-
cal, and molecular evidence indicates that FTD and
amyotrophic lateral sclerosis (ALS) are closely related con-
ditions [3].
In addition to pathogenic mutations in the microtubule
binding protein tau [4,5], rare mutations in other genes
also cause FTD, such as those encoding valosin-contain-
ing protein, an AAA-type ATPase associated primarily with
the endoplasmic reticulum [6], and CHMP2B, a compo-
nent of the endosomal sorting complex required for trans-
port III [7]. Mutations in progranulin located on
chromosome 17 also cause FTD in some patients without
tau pathology [8,9]. Progranulin is a secreted molecule,
and many pathogenic mutations lead to progranulin hap-
loinsufficiency. The pathogenic mechanism of FTD
caused by progranulin deficiency is not known, but one of
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the pathological hallmarks is tau-negative and ubiquitin-
positive neuronal inclusions that contain TDP-43 and its
fragments [10-13]. Genetic mutations in TDP-43  are
responsible for some sporadic and familial amyotrophic
lateral sclerosis (ALS) [14-16], further reinforcing the
notion that FTD and ALS are closely related conditions,
referred to as TDP-43 proteinopathies [17]. In healthy
cells, TDP-43 mostly resides in the nucleus. In diseased
neurons, however, TDP-43 is excluded from the nucleus
and aggregates in the cytosol [10]. Moreover, in axot-
omized motor neurons, TDP-43 expression is dramati-
cally increased and becomes prominently localized in the
cytosol [18]. These findings raise the possibility that loss
of the normal function of TDP-43, especially in the
nucleus, contributes to the initiation or progression of dis-
ease.
TDP-43 is a ubiquitously expressed RNA-binding protein
that contains two RNA recognition motifs, a glycine-rich
region, a nuclear localization signal, and a nuclear export
signal [19]. It is not known which aspects of cellular phys-
iology are regulated by TDP-43. TDP-43 is primarily local-
ized in the nucleus at the active sites of transcription and
cotranscriptional splicing in mammalian neurons [20].
Indeed, limited experimental evidence indicates that TDP-
43 is involved in transcription [21] and splicing [22,23]
and possibly in mRNA transport and local translation as
well [24]. TDP-43 and many other proteins form a large
complex with Drosha [25], but its possible involvement
in the microRNA pathway remains to be further explored.
To understand how TDP-43 contributes to the pathogen-
esis of FTD and ALS, it is essential to dissect its normal
functions in postmitotic neurons.
TDP-43 is highly conserved at the amino acid level from
flies to humans, suggesting an evolutionarily conserved
function [19,23,26]. To investigate the normal roles of
TDP-43 in postmitotic neurons, we used dendrites of sen-
sory neurons in the Drosophila peripheral nervous system
(PNS) as our assay system and performed both gain- and
loss-of-function genetic studies. We also examined the
functional significance of some genetic mutations in TDP-
43 that are associated with ALS. Our findings support the
notion that a TDP-43 loss-of-function mechanism may
contribute to the pathogenesis of FTD and ALS.
Methods
Fly strains and genetics
All flies were raised on standard food medium and kept at
25°C.  dTDP-43  RNAi lines 38377 and 38379 were
obtained from the Vienna Drosophila  RNAi Center
(VDRC). The dTDP-43Q367X mutant allele was identified
from the Seattle Drosophila  TILLING Project (Fly-TILL,
Fred Hutchinson Cancer Research Center) using specific
tilling primers (Additional file 1). dTDP-43Q367X/CyO,
GFP flies were crossed with Pin/CyO, GFP; Gal4221, UAS-
mCD8-GFP  to establish the stock dTDP-43Q367X/CyO,
GFP; Gal4221, UAS-mCD8-GFP/+. The Gal4221 driver was
used to label ddaE and ddaF neurons with mCD8-GFP
and drive the expression of transgenes [27]. To visualize
dendritic phenotypes of ddaE and ddaF neurons in third
instar larvae, we crossed dTDP-43Q367X/CyO, GFP; Gal4221,
UAS-mCD8-GFP/+ flies with dTDP-43Q367X/CyO, GFP or
w1118  flies to generate dTDP-43Q367X/dTDP-43Q367X;
Gal4221,  UAS-mCD8-GFP/+  or  dTDP-43Q367X/+;  Gal4221,
UAS-mCD8-GFP/+  third instar larvae. For RNAi expres-
sion, dTDP-43Q367X/CyO, GFP; Gal4221, UAS-mCD8-GFP/+
flies were crossed with UAS-dTDP-43 RNAi lines (VDRC
38377 and 38379) to generate dTDP-43Q367X/+; Gal4221,
UAS-mCD8-GFP/38377, and dTDP-43Q367X/38379;
Gal4221, UAS-mCD8-GFP/+ third instar larvae for pheno-
typic analysis. For transgene overexpression, Gal4221,
UAS-mCD8-GFP  flies were crossed with UAS-dTDP-43,,
UAS-hTDP-43, UAS-hTDP-43-M337V, or UAS-hTDP-43-
Q331K  transgenic lines. In the above experiments,
Gal4221, UAS-mCD8-GFP/+ third larvae served as the con-
trol.
Generation of transgenic Drosophila lines
Full-length hTDP-43 cDNA was cloned from HEK293 cells
(provided by Dr. J.-A. Lee). To generate UAS-hTDP-43,
UAS-hTDP-43-M337V, UAS-hTDP-43-Q331K, and UAS-
hTDP-43-C-terminal fragment (amino acids 209-414)
constructs, the corresponding primers (Additional file 1)
were used to amplify DNA fragments, which were then
cloned into the pUAST vector. To generate UAS-dTDP-43
constructs, the full-length dTDP-43 coding sequence was
amplified from the cDNA plasmid GH09868 (Drosophila
Genomics Resource Center) and cloned into the pUAST
vector. These constructs were confirmed by sequencing
and microinjected into wild-type (w1118) embryos to gen-
erate transgenic lines.
Antibody production and western blot
Anti-dTDP-43 polyclonal antibody was generated by
immunizing rabbits with a peptide fragment spanning
amino acids 179-192 (Thermo Fisher Scientific). For pro-
tein expression analysis, adult flies were frozen in ethanol
with dry ice and vortexed to remove heads. Approximately
30 heads from each genotype were homogenized in 50 μl
of lysis buffer (0.137 M NaCl, 20 mM Tris, pH 8.0, 10%
glycerol, 1% NP-40, 0.1% SDS, 0.1% sodium deoxycho-
late, 1 mM DTT, Pierce protease inhibitors and phos-
phatase inhibitors). Homogenate was heated at 65°C for
10 min and centrifuged at 4°C for 10 min at 13,000 rpm.
Protein concentrations were determined using Bradford
Assay (Bio-Rad).
Supernatant containing 10 μg of protein was separated on
a 10% acrylamide SDS gel and transferred to a PVDF
membrane (Bio-Rad) in a wet transfer system at 4°C for
60 min at 100 V. The membrane was incubated in block-Molecular Brain 2009, 2:30 http://www.molecularbrain.com/content/2/1/30
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ing solution containing 5% milk in TBST (25 mM Tris-
HCl, 137 mM NaCl, 3 mM KCl, pH 7.4, and 0.1% Tween-
20) at 4°C overnight, with dTDP-43 antibody (1:1000 in
blocking solution) at room temperature for 3 h, and
finally with anti-rabbit HRP-conjugated secondary anti-
body (Jackson Immunoresearch; 1:10,000) for 1 h. The
signal was visualized with chemiluminescent substrate
(Supersignal West Pico, Pierce). For other western blot
analyses, the primary antibodies were hTDP-43 antibody
(1:1000; 10782-2-AP, Proteintech), and β-actin antibody
(1:1500; Cell Signaling).
Quantitative RT-PCR (qRT-PCR) analysis
Total RNAs were extracted from adult heads with Trizol
(Invitrogen) and used as templates to generate cDNAs
with TaqMan reverse transcription reagent (Applied Bio-
systems). cDNAs were used as templates for qRT-PCR in a
final volume of 25 μl. A standard curve was run in each
PCR reaction. Individual values were normalized to the
value of the gene encoding the ribosomal protein RP-49.
Two pairs of primers were designed to detect dTDP-43
transcripts (Additional file 2). All reactions were per-
formed three times. Relative mRNA expression was calcu-
lated using the standard curve method and the delta-delta
Ct method.
Mosaic analysis with a repressible cell marker (MARCM)
MARCM analysis of sensory neurons in the Drosophila
PNS was performed as described [28]. First, the dTDP-
43Q367X allele was recombined onto the chromosome con-
taining FRTG13. FRTG13, dTDP-43Q367X/CyO or FRTG13/CyO
male flies were crossed with Gal4C155, UAS-mCD8-GFP,
hs-FLP1; FRTG13,  Gal80/CyO  virgin females to generate
Gal4C155,  UAS-mCD8-GFP, hs-FLP1/+; FRTG13,  Gal80/
FRTG13, dTDP-43Q367X and Gal4C155, UAS-mCD8-GFP, hs-
FLP1/+; FRTG13,  Gal80/FRTG13  embryos, respectively.
Embryos from these crosses were collected on grape agar
plates for 3 h in a 25°C incubator. The embryos were aged
for 3 h and heat-shocked in a 37°C water bath for 40 min
to induce mitotic recombination. The embryos were then
kept in a moisture chamber at 25°C for 3-4 days. Third
instar larvae were collected, and larvae that contained a
single mCD8::GFP-labeled dorsal cluster PNS neuron
were selected under a Nikon fluorescence dissection
microscope. Images of the dendritic morphology of single
DA neurons were recorded with a confocal microscope
(Nikon, D-Eclipse C1). The significance of differences in
dendritic branching complexity was determined with Stu-
dent's t test.
Quantitative Analysis of dendritic ends of sensory neurons
The dendritic morphology of GFP-labeled dorsal sensory
neurons was recorded with a confocal microscope
(Nikon, D-Eclipse C1), and dendritic branches of ddaE or
ddaF neurons in the A3 dorsal cluster were counted as
described [28]. Briefly, dendritic ends of DA neuron
images were identified visually and highlighted with dots,
which were counted with Adobe Photoshop software. The
data were analyzed by Student's t test.
Results
dTDP-43 promotes dendritic branching of sensory neurons 
in Drosophila
To examine neuronal functions of dTDP-43, we generated
multiple UAS-dTDP-43 transgenic fly lines with insertion
sites on different chromosomes. Because dendritic
branching patterns are critically important for neuronal
function and connectivity and dendritic defects are associ-
ated with many neurological disorders [29,30], we
focused our functional analysis of TDP-43 on dendrites.
To do so, we used the sensory neurons in Drosophila larvae
as our assay system, which has been useful in uncovering
molecular mechanisms of dendritic morphogenesis [31].
To drive transgene expression, we used the neuronal sub-
type-specific driver Gal4221, which targets gene expression
in two sensory neurons only in each hemisegment [27].
Ectopic expression of dTDP-43 markedly increased the
number of small terminal dendritic branches (Figure 1B).
For instance, the number of dendritic ends increased from
29.2 ± 1.0 (n = 14) to 51.2 ± 3.0 (n = 10) (P < 0.001) in
ddaE neurons, and from 22.8 ± 1.0 (n = 14) to 39.9 ± 1.9
(n = 10) (P < 0.001) in ddaF neurons (Figure 1C). Inter-
estingly, most of the small terminal dendritic branches
caused by dTDP-43 expression were concentrated near the
cell body of ddaE neurons (Figure 1B). This effect of
dTDP-43 was confirmed in studies with other UAS-dTDP-
43 transgenic fly lines with different insertion sites on the
second or third chromosomes (data not shown).
dTDP-43 is required for normal viability of adult flies
Next, we generated dTDP-43 loss-of-function mutant flies.
We used the service from the Seattle Drosophila TILLING
Project (Fred Hutchinson Cancer Research Center) and
obtained several fly lines in which point mutations were
found in dTDP-43. One, a nonsense mutation with a sin-
gle nucleotide change from G to A, introduced a stop
codon at amino acid 367 (Figure 2A). This mutation was
confirmed by sequencing PCR products amplified from
the genomic DNA of dTDP-43Q367X heterozygous adult
flies (Figure 2B). To confirm that this mutant allele is a
protein-null allele, we raised a rabbit polyclonal antibody
against the dTDP-43 peptide fragment spanning amino
acids 179-192. On western blot, this antibody recognized
a protein band with the predicted molecular weight of
dTDP-43 in lysates from adult wildtype but not in dTDP-
43Q367X mutant flies (Figure 2C). The intensity of this
band was decreased by about half in Df(2R)106/+ hetero-
zygous flies (data not shown). Since this antibody did not
detect the putative truncated dTDP-43 protein in mutant
flies (Figure 2C), it is likely that the truncated dTDP-43
protein is unstable, in addition to the reduced abundanceMolecular Brain 2009, 2:30 http://www.molecularbrain.com/content/2/1/30
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of the dTDP-43  mRNA containing the premature stop
codon (Figure 2D). Thus, dTDP-43Q367X is a protein null
allele.
Homozygosity for dTDP-43Q367X  was semi-lethal, with
some mutant adult flies surviving to adulthood. For
instance, the ratio of dTDP-43Q367X/CyO to dTDP-43Q367X/
dTDP-43Q367X progenies of dTDP-43Q367X/CyO  flies was
about 4-5:1, instead of the expected 2:1 ratio for nonlethal
mutations. This finding is consistent with a recent report
that dTDP-43 deletion mutations in were semi-lethal as
well [26]. Expression of UAS-dTDP-43 RNAi (38377 or
38379, VDRC) driven by tubulin-Gal4 resulted in a similar
lethal phenotype. Overexpression of dTDP-43 with the
pan-neuronal Gal4C155 driver also led to a similar lethal
phenotype, indicating that the proper level of dTDP-43
expression in the nervous system is required for normal
viability. Indeed, ectopic expression of dTDP-43 in the eye
caused a severe retinal degeneration phenotype (data not
shown).
Loss of dTDP-43 activity reduces dendritic branching
To examine dendritic phenotypes caused by loss of dTDP-
43 activity, we first expressed mCD8-GFP under the con-
trol of Gal4221 in ddaE and ddaF neurons in wildtype or
dTDP-43Q367X  homozygous mutant third instar larvae.
Compared with wildtype neurons (Figure 3A), loss of
dTDP-43 function significantly decreased dendritic
branching (Figure 3B). For instance, the number of den-
dritic ends of ddaE neurons in the A3 segment decreased
from 31.4 ± 1.0 (n = 17) in wildtype larvae to 24.4 ± 0.5
(n = 16) in dTDP-43Q367X homozygous mutant larvae (P <
0.001) (Figure 3C). A similar decrease was observed in
ddaF neurons (Figure 3D).
dTDP-43 promotes dendritic branching in Drosophila Figure 1
dTDP-43 promotes dendritic branching in Drosophila. (A) Schematic representation of the domain structure of dTDP-
43. RRM: RNA recognition motif. GRR: glycine-rich region. (B) Dendritic phenotypes of ddaE and ddaF sensory neurons in the 
A3 segment of third instar larvae that are either wildtype (a) or overexpress dTDP-43 with the Gal4221 driver (b). (C) Quanti-
fication of dendritic ends of ddaE and ddaF neurons. The number of neurons examined is indicated in each column. Values are 
mean ± SEM. ***P < 0.001.
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Since ectopic overexpression of dTDP-43 markedly
increased dendritic branching, it would be difficult to
interpret results obtained by using the UAS-Gal4 system
to rescue the dendritic phenotype in dTDP-43Q367X
mutants. Therefore, to further confirm that loss of dTDP-
43 activity reduces dendritic branching, we used two inde-
pendent  dTDP-43  RNAi lines obtained from VDRC to
knock down dTDP-43 expression in these neurons. Again,
the number of dendritic ends was decreased in ddaE (Fig-
ure 3C) and ddaF neurons (Figure 3D). These findings
demonstrate that dTDP-43 has an essential role in pat-
terning dendritic formation in vivo.
dTDP-43 has a cell-autonomous function in dendritic 
branching
In the RNAi experiment described above, dTDP-43 activ-
ity was knocked down in only a small number of sensory
neurons, suggesting that dTDP-43 functions in a cell-
autonomous manner to control dendritic branching. To
further confirm this possibility, we used the mosaic anal-
ysis with a repressible cell marker (MARCM) technique,
which allows one to generate GFP-labeled single neurons
containing a mutation of a gene of interest in a mostly
wildtype  Drosophila  larva or adult [32]. Using this
approach, we found that compared with wildtype ddaE
neurons (Figure 4A), loss of dTDP-43 function specifically
in ddaE neurons reduced dendritic branching (Figure 4B),
consistent with the genetic analysis of these neurons in
dTDP-43Q367X  homozygous mutant larvae (Figure 3).
dTDP-43Q367X mutant ddaE neurons in the A3 segment
had fewer dendritic ends than wildtype neurons labeled
by MARCM (23.3 ± 3.4 (n = 6) vs. 31.3 ± 4.9 (n = 6) (P <
0.001). This result indicates that dTDP-43 functions in a
cell-autonomous manner to regulate dendritic branching.
Generation of a dTDP-43 null allele Figure 2
Generation of a dTDP-43 null allele. (A) Schematic representation of the truncated dTDP-43 protein caused by the single 
nonsense nucleotide mutation at amino acid 367. (B) Sequencing of the PCR fragment amplified from the genomic DNA of het-
erozygous flies confirmed the single nucleotide mutation from G to A. (C) Western blot analysis of protein lysates from the 
heads of wildtype (WT) or dTDP-43Q367X homozygous mutant adult flies confirmed the absence of full-length dTDP-43 in 
mutants. The asterisk indicates a nonspecific band recognized by this antibody. The rabbit polyclonal antibody was raised 
against the peptide fragment spanning amino acids 179-192 and did not recognize the putative truncated dTDP-43 in mutants, 
indicating instability of the mutant dTDP-43 mRNA or protein. (D) qRT-PCR analysis of dTDP-43 mRNA levels in wildtype and 
dTDP-43Q367X mutant flies. Two pairs of primers (Additional file 2) used for qRT-PCR yielded similar results. Values are mean ± 
SD. *P < 0.05.
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hTDP-43 promotes dendritic branching in fly neurons and 
ALS-associated disease mutations attenuates this activity
TDP-43 is an evolutionarily conserved protein whose
amino acid sequence is highly homologous in flies and
humans. To examine whether human TDP-43 (hTDP-43)
also promotes dendritic branching, we generated multiple
lines of UAS-hTDP-43 transgenic flies (Figure 5A). The C-
terminal fragment of hTDP-43 and several point muta-
tions have been implicated in the pathogenesis of FTD
and ALS [10,14-17], but the mechanisms are unclear. To
address this issue, we also generated multiple transgenic
fly lines to express these mutant hTDP-43 proteins (Figure
5A). The level of transgene expression can vary depending
on the insertion site in the genome. We therefore per-
formed western blot analysis and selected individual
transgenic fly lines that, when crossed with the GMR-Gal4
line, expressed hTDP-43WT and hTDP-43Q331K or hTDP-
43M337V at comparable levels (Figure 5B).
Ectopic expression of hTDP-43 in Drosophila neurons also
promoted dendritic branching (Figure 6). The number of
dendritic ends for ddaE neurons was increased from 29.5
± 0.8 (n = 14) (Figure 6A) to 55 ± 1.6 (n = 29) (P < 0.001)
(Figure 6B, E). A similar effect was observed for ddaF neu-
rons (Figure 6B, F). The ectopic expression of the hTDP-43
C-terminal fragment did not affect dendrite branching
(data not shown). As with dTDP-43, ectopic expression of
hTDP-43 increased in dendritic ends mostly near the cell
body (Figure 6B). These findings suggest that hTDP-43
and dTDP-43 are functionally conserved and likely exert
their effects on dendritic branching through the same
genetic pathways.
Both of those ALS-associated mutant proteins promoted
dendritic branching to a much lesser extent than wildtype
hTDP-43 (Figure 6C). ddaE neurons expressing hTDP-
43WT had 55 ± 1.6 (n = 29) dendritic ends but the neurons
expressing hTDP-43M337V or hTDP-43Q331K had only 41.1
± 1.5 (n = 18) or 44.3 ± 2.0 (n = 21) dendritic ends, respec-
tively (P  < 0.001) (Figure 6E). A similar effect was
observed for ddaF neurons (Figure 6F). Thus, ALS-associ-
ated mutations in hTDP-43 attenuated its dendrite-pro-
Loss of dTDP-43 activity led to decreased dendritic branching Figure 3
Loss of dTDP-43 activity led to decreased dendritic branching. (A) Dendritic branching pattern of ddaE and ddaF neu-
rons in a wildtype larva. (B) ddaE and daF neurons in a dTDP-43Q367X homozygous mutant third instar larva. The neurons in A 
and B were labeled with mCD8-GFP under the control of Gal4221. (C) Quantification of dendritic ends of ddaE neurons. (D) 
Quantification of dendritic ends of ddaF neurons. The number of neurons examined is indicated in each column. Values are 
mean ± SEM ***P < 0.001. The effect of loss of dTDP-43 function on dendritic formation was confirmed by expressing two 
independent UAS-dTDP-43 RNAi constructs, 38377 and 38379, in ddaE and ddaF neurons in the dTDP-43Q367X/+ background.
A B
C
Control dTDP-43
Q367X
N
u
m
b
e
r
 
o
f
f
 
D
e
n
d
r
i
t
i
c
 
E
n
d
s
30
20
10
0
17
WT -/+ 38377
17
n.s.
-/-
16 10 15
***
*** ***
38379
ddaE
N
u
m
b
e
r
 
o
f
 
D
e
n
d
r
i
t
i
c
 
E
n
d
s
30
20
10
0
17
WT -/+ 38377
17
n.s.
-/-
16 10 15
*** *** ***
38379
D
ddaFMolecular Brain 2009, 2:30 http://www.molecularbrain.com/content/2/1/30
Page 7 of 10
(page number not for citation purposes)
moting activity, raising the possibility that loss-of-
function mechanism as a contributing factor to the disor-
der.
Discussion
The pathological role of TDP-43 was first recognized by its
presence in ubiquitin-positive but tau-negative inclusions
in diseased neurons of FTD and ALS patients [10,11].
TDP-43 pathology has two characteristic features. First,
TDP-43 is proteolytically processed, and phosphorylated
C-terminal fragments of approximately 20-25 kDa are
present in the insoluble inclusions [10]. Indeed, ectopic
expression of these fragments in cultured cells results in
aggregation [33]. Second, TDP-43 is transported from the
nucleus, where it predominantly resides in healthy cells.
These findings suggest that TDP-43 may contribute to
neurodegeneration through both a toxic gain-of-function
mechanism and a loss-of-function mechanism. These pos-
sibilities are not mutually exclusive. However, the precise
roles of TDP-43 in postmitotic neurons remain largely
unknown.
Since TDP-43 is highly conserved at the amino acid
sequence level from flies to humans, Drosophila offers a
powerful model system to examine the endogenous func-
tions of TDP-43. We obtained dTDP-43 null mutant flies
and found that dTDP-43 is required for normal viability,
consistent with a study published during the preparation
of our manuscript [26]. TDP-43 knockout mice have not
been reported yet. Considering the high degree of conser-
vation between dTDP-43 and hTDP-43, it is possible that
TDP-43 is also essential for normal development in mam-
mals. At the cellular level, multiple lines of evidence from
our current study indicate that TDP-43 promotes den-
dritic branching in postmitotic neurons. This conclusion
was based on overexpression studies, RNAi knockdown,
and genetic analysis of a dTDP-43  null allele. TDP-43
seems to also regulate axonal structures at the Drosophila
neuromuscular junction (NMJ) [26]. These findings indi-
MARCM analysis reveals a cell-autonomous role for dTDP-43 in dendritic branching Figure 4
MARCM analysis reveals a cell-autonomous role for dTDP-43 in dendritic branching. (A) A wildtype ddaE neuron 
labeled with GFP by MARCM. (B) A dTDP-43Q367X mutant ddaE neuron labeled with GFP by MARCM. (C) Quantification of 
dendritic ends of ddaE neurons. The number of neurons examined is indicated in each column. Values are mean ± SEM. ***P < 
0.001.
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cate an essential role for TDP-43 in neuronal structural
integrity.
In many neurodegenerative diseases, defects in synaptic
connections are probably one of the earliest alterations
preceding neurodegeneration [34]. Recent imaging stud-
ies in human brains suggest that specific functional con-
nectivity networks are compromised in specific
neurodegenerative conditions [35]. It is conceivable that
loss of the normal nuclear function of TDP-43 in specific
vulnerable neurons reduces dendritic complexity, which
in turn leads to compromised neuronal connectivity in
that specific neuronal circuitry. Thus, exclusion of TDP-43
from the nucleus through unknown pathways in diseased
neurons may represent a loss-of-function mechanism that
may contribute to the pathogenesis of FTD and ALS.
Drosophila is also an excellent model system for studying
human disease proteins. We found that hTDP-43 also pro-
motes dendritic branching in Drosophila neurons, indicat-
ing a functional conservation. More importantly, two
point mutations associated with ALS attenuated the den-
drite-promoting activity of hTDP-43. Both are located in a
C-terminal region that mediates protein-protein interac-
tions [36]. Thus, these mutations may compromise the
normal functions of TDP-43 in neurons. It was reported
that these missense mutations might also enhance the for-
mation of TDP-43 aggregates [37]. Thus, multiple patho-
genic mechanisms may work in concert to promote
disease initiation and/or progression.
Conclusion
Overexpression of dTDP-43 or hTDP-43 in vivo signifi-
cantly increased dendritic branching in a Drosophila assay
system. RNAi knockdown and genetic analysis of a dTDP-
43 null allele revealed a cell-autonomous role for dTDP-
43 in promoting dendrite formation. Mutations associ-
ated with some forms of ALS reduced the dendrite-pro-
moting activity of hTDP-43, suggesting a loss-of-function
pathogenic mechanism. These findings support the
notion that loss of normal TDP-43 function may contrib-
ute to the pathogenesis of FTD and ALS. The fly model
reported here and newly generated relevant reagents will
facilitate studies to further elucidate the underlying
molecular mechanisms.
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hTDP-43 promotes dendritic branching in Drosophila neurons and disease-related mutations in hTDP-43 reduce this activity Figure 6
hTDP-43 promotes dendritic branching in Drosophila neurons and disease-related mutations in hTDP-43 
reduce this activity. (A-D) Images of ddaE and ddaF neurons that express mCD8-GFP (A), wildtype hTDP-43 (B), hTDP-43 
with the Q331K mutation (C), and hTDP-43 with the M337V mutation (D). The asterisk indicates another sensory neuron in 
the cluster that occasionally was weakly labeled with GFP expressed with the Gal4221 driver. (E) Quantification of dendritic 
ends of ddaE neurons. (F) Quantification of dendritic ends of ddaF neurons. The number of neurons examined is indicated in 
each column. Values are mean ± SEM. ***P < 0.001.
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